BioCryst Pharmaceuticals Inc (BCRX)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Amy E. McKeeIndependent Director | -11.18k | 100.28k | 売り | 8.97 | 18.75k | -37.35% |
| 2026-05-13 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -62.50k | 281.25k | Derivative Exercise and Sale | 5.04 - 9.54 | 147.98k | - |
| 2026-03-20 | Ms. Theresa Marie HeggieIndependent Director | -49.93k | 190.24k | Derivative Exercise and Sale | 6.30 - 10.11 | 52.85k | - |
| 2026-03-16 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -150.00k | 546.00k | Derivative Exercise and Sale | 5.51 - 9.15 | 147.98k | - |
| 2026-03-02 | Mr. Jon P. StonehouseDirector | -306.00k | 1.66M | Derivative Exercise and Sale | 3.22 - 8.64 | 1.04M | - |
| 2025-12-19 | Mr. Jon P. StonehouseDirector | -61.79k | 457.89k | Sale to Issuer | 7.41 | 1.04M | -5.63% |
| 2025-12-22 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -21.77k | 166.56k | Automatic Disposition | 7.65 | 146.03k | -12.98% |
| 2025-12-19 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -16.90k | 125.24k | Sale to Issuer | 7.41 | 146.03k | -10.37% |
| 2025-12-22 | Mr. Charles K. GayerCEO, President & Director | 74.23k | 371.90k | Derivative Exercise and Retained Stock | 3.22 - 5.51 | 361.62k | 25.83% |
| 2025-12-19 | Mr. Charles K. GayerCEO, President & Director | -11.48k | 85.04k | Sale to Issuer | 7.41 | 361.62k | -3.08% |
| 2025-12-18 | Mr. Jon P. StonehouseDirector | -20.00k | 0.00 | Other Disposition | - | 975.62k | -2.01% |
| 2025-12-12 | Mr. Charles K. GayerCEO, President & Director | -8.18k | 61.93k | Sale to Issuer | 7.57 | 258.88k | -3.06% |
| 2025-12-15 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -21.21k | 162.26k | Automatic Disposition | 7.65 | 146.03k | -12.68% |
| 2025-12-12 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -8.54k | 64.65k | Sale to Issuer | 7.57 | 146.03k | -5.53% |
| 2025-12-12 | Mr. Jon P. StonehouseDirector | -27.37k | 207.18k | Sale to Issuer | 7.57 | 975.62k | -2.73% |
| 2025-12-01 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -91.00k | 353.48k | Derivative Exercise and Sale | 3.22 - 7.10 | 146.03k | - |
| 2025-12-02 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -50.91k | 367.22k | 売り | 7.21 | 146.03k | -25.85% |
| 2025-12-03 | Ms. Alane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary | -19.77k | 151.24k | Automatic Disposition | 7.65 | 146.03k | -11.92% |
| 2025-11-13 | Ms. A. Machelle SandersIndependent Director | -9.60k | 68.54k | Automatic Disposition | 7.14 | 18.14k | -34.60% |
| 2025-08-13 | Ms. Theresa Marie HeggieIndependent Director | -70.00k | 292.17k | Derivative Exercise and Sale | 2.91 - 8.51 | 52.85k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。